Back to Search Start Over

The Effects of Varenicline on Alcohol Seeking and Self-Administration in Baboons.

Authors :
Kaminski, Barbara J.
Weerts, Elise M.
Source :
Alcoholism: Clinical & Experimental Research; Feb2014, Vol. 38 Issue 2, p376-383, 8p
Publication Year :
2014

Abstract

Background Nicotinic acetylcholine receptors (n ACh Rs) may play a critical role in alcohol reinforcement and consumption. The effects of varenicline, an n ACh R partial agonist, on alcohol seeking and self-administration responses were evaluated in 2 groups of baboons trained under a 3-component chained schedule of reinforcement ( CSR). Methods Alcohol (4% w/v; n = 4; alcohol group) or a preferred nonalcoholic beverage ( n = 4; control group) was available for self-administration only in component 3 of the CSR. Responses in component 2, required to gain access to alcohol, provided indices of seeking behavior. Varenicline (0.032 to 0.32 mg/kg; 0.32 mg/kg twice daily [BID]) and vehicle were administered before CSR sessions subchronically (5 consecutive days). Higher doses (0.56, 1.0 mg/kg) were attempted, but discontinued due to adverse effects. Results Subchronic varenicline administration significantly ( p < 0.05) decreased the seeking response rate and increased the time to complete the response requirement to gain access to the daily supply of alcohol at the higher doses (0.32 mg/kg, 0.32 mg/kg BID dosing) in the alcohol group compared with the control group. Mean number of drinks was significantly decreased ( p < 0.05), but effects did not differ between groups. The pattern of drinking was characterized by a high rate during an initial bout. Number of drinks during and duration of the initial bout were significantly decreased in the alcohol group, compared with the control group, at 0.32 mg/kg ( p < 0.05). Conclusions Varenicline may be clinically useful for reducing alcohol-seeking behaviors prior to alcohol exposure. Given the modest effects on drinking itself, varenicline may be better suited as a treatment in combination with a pharmacotherapy that significantly reduces alcohol consumption. [ABSTRACT FROM AUTHOR]

Details

Language :
English
Volume :
38
Issue :
2
Database :
Complementary Index
Journal :
Alcoholism: Clinical & Experimental Research
Publication Type :
Academic Journal
Accession number :
94086554
Full Text :
https://doi.org/10.1111/acer.12233